Nucleai Secures $14M to Enhance Clinical Trial Enrollment with Spatial AI Biomarker
What You Should Know:
– Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of Merck KGaA.
– The investment brings Nucleai’s total funding to $60M…
Continue Reading